| Print
Veru Inc (VERU)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
Address
48 NW 25th Street
Suite 102
Miami
FL
USA
33137
Telephone
+1 305 5096897
Forecast key dates
| Name | Key Date |
|---|---|
| Veru Inc First Quarter Earnings Conference Call for 2027 | 2027-02-11T08:00:00 |
| Veru Inc First Quarter Earnings Results for 2027 | 2027-02-11T00:00:00 |
| Veru Inc Fourth Quarter Earnings Conference Call for 2026 | 2026-12-17T08:00:00 |
| Veru Inc Fourth Quarter Earnings Results for 2026 | 2026-12-17T00:00:00 |
| Veru Inc Annual Report for 2026 | 2026-12-17T00:00:00 |
| Veru Inc Third Quarter Earnings Conference Call for 2026 | 2026-08-12T08:00:00 |
| Veru Inc Third Quarter Earnings Results for 2026 | 2026-08-12T00:00:00 |
| Veru Inc Second Quarter Earnings Conference Call for 2026 | 2026-05-08T08:00:00 |
| Veru Inc Second Quarter Earnings Results for 2026 | 2026-05-08T00:00:00 |
| Veru Inc Annual General Meeting for 2026 | 2026-03-13T09:00:00 |
| Veru Inc First Quarter Earnings Conference Call for 2026 | 2026-02-11T08:00:00 |
| Veru Inc First Quarter Earnings Result for 2026 | 2026-02-11T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.